Sawai Group Holdings Co., Ltd. (4887.T)
JPY 2045.0
(-0.87%)
JPY 2045.0
(-0.87%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 382.02 Billion JPY | 4.9% |
| 2022 | 364.16 Billion JPY | 4.2% |
| 2021 | 349.5 Billion JPY | -11.15% |
| 2020 | 393.34 Billion JPY | 2.22% |
| 2019 | 384.81 Billion JPY | 3.2% |
| 2018 | 372.88 Billion JPY | 4.03% |
| 2017 | 358.45 Billion JPY | 58.88% |
| 2016 | 225.6 Billion JPY | 9.26% |
| 2015 | 206.49 Billion JPY | 24.26% |
| 2014 | 166.17 Billion JPY | 11.27% |
| 2013 | 149.34 Billion JPY | 16.82% |
| 2012 | 127.84 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 372.89 Billion JPY | -2.39% |
| 2023 FY | 382.02 Billion JPY | 4.9% |
| 2023 Q1 | 389.4 Billion JPY | 6.93% |
| 2023 Q2 | 397.72 Billion JPY | 2.14% |
| 2023 Q4 | 382.02 Billion JPY | -2.25% |
| 2023 Q3 | 390.79 Billion JPY | -1.74% |
| 2022 Q1 | 365.35 Billion JPY | 4.54% |
| 2022 FY | 364.16 Billion JPY | 4.2% |
| 2022 Q4 | 364.16 Billion JPY | -0.18% |
| 2022 Q3 | 364.81 Billion JPY | -4.49% |
| 2022 Q2 | 381.98 Billion JPY | 4.55% |
| 2021 Q2 | 398.66 Billion JPY | 1.58% |
| 2021 Q1 | 392.47 Billion JPY | -0.22% |
| 2021 FY | 349.5 Billion JPY | -11.15% |
| 2021 Q4 | 349.5 Billion JPY | -14.99% |
| 2021 Q3 | 411.12 Billion JPY | 3.13% |
| 2020 Q1 | 383.44 Billion JPY | -0.36% |
| 2020 FY | 393.34 Billion JPY | 2.22% |
| 2020 Q4 | 393.34 Billion JPY | 0.63% |
| 2020 Q2 | 388.96 Billion JPY | 1.44% |
| 2020 Q3 | 390.86 Billion JPY | 0.49% |
| 2019 Q3 | 388.23 Billion JPY | 1.67% |
| 2019 Q1 | 374.89 Billion JPY | 0.54% |
| 2019 Q2 | 381.84 Billion JPY | 1.85% |
| 2019 Q4 | 384.81 Billion JPY | -0.88% |
| 2019 FY | 384.81 Billion JPY | 3.2% |
| 2018 Q3 | 373.28 Billion JPY | 1.27% |
| 2018 FY | 372.88 Billion JPY | 4.03% |
| 2018 Q4 | 372.88 Billion JPY | -0.11% |
| 2018 Q2 | 368.58 Billion JPY | 1.65% |
| 2018 Q1 | 362.61 Billion JPY | 1.16% |
| 2017 Q4 | 358.45 Billion JPY | 1.29% |
| 2017 FY | 358.45 Billion JPY | 58.88% |
| 2017 Q1 | 354.92 Billion JPY | 60.21% |
| 2017 Q2 | 345.92 Billion JPY | -2.54% |
| 2017 Q3 | 353.89 Billion JPY | 2.3% |
| 2016 Q3 | 214.58 Billion JPY | -0.6% |
| 2016 Q2 | 215.87 Billion JPY | 1.02% |
| 2016 FY | 225.6 Billion JPY | 9.26% |
| 2016 Q4 | 221.53 Billion JPY | 3.24% |
| 2016 Q1 | 213.7 Billion JPY | 3.49% |
| 2015 Q2 | 186.23 Billion JPY | 4.0% |
| 2015 FY | 206.49 Billion JPY | 24.26% |
| 2015 Q4 | 206.49 Billion JPY | 2.31% |
| 2015 Q3 | 201.83 Billion JPY | 8.37% |
| 2015 Q1 | 179.07 Billion JPY | 7.76% |
| 2014 Q1 | 147.69 Billion JPY | -1.1% |
| 2014 Q2 | 158.08 Billion JPY | 7.03% |
| 2014 Q3 | 162.44 Billion JPY | 2.76% |
| 2014 Q4 | 166.17 Billion JPY | 2.3% |
| 2014 FY | 166.17 Billion JPY | 11.27% |
| 2013 FY | 149.34 Billion JPY | 16.82% |
| 2013 Q4 | 149.34 Billion JPY | 6.65% |
| 2013 Q3 | 140.03 Billion JPY | 2.9% |
| 2013 Q2 | 136.09 Billion JPY | 4.56% |
| 2013 Q1 | 130.15 Billion JPY | 1.81% |
| 2012 Q3 | 128.02 Billion JPY | -1.89% |
| 2012 Q4 | 127.84 Billion JPY | -0.14% |
| 2012 Q2 | 130.49 Billion JPY | 0.0% |
| 2012 FY | 127.84 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -944.552% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 97.472% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 57.904% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 73.038% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -2377.289% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | -45.033% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -122.595% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 72.591% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -2123.267% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | -16.195% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -140.569% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -399.639% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -671.018% |
| Tsumura & Co. | 428.25 Billion JPY | 10.795% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | -46.409% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -186.306% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 11.292% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -347.691% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -153.78% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -115.008% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -2439.04% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -391.615% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -2388.424% |
| MedRx Co., Ltd | 2.05 Billion JPY | -18517.154% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -1916.136% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -14881.333% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -18756.769% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -309.405% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -8963.851% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 50.606% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -1093.675% |